Pediatric Study Incentive Could Be Tax Credit, Not Exclusivity - Rep. Pallone
This article was originally published in The Tan Sheet
Executive Summary
Tax credits or reimbursements may be alternative incentives to encourage manufacturers to conduct pediatric studies, Rep. Frank Pallone (D-N.J.) suggested during a House Energy & Commerce/Health Subcommittee hearing May 3.
You may also be interested in...
House Commerce Health Subcommittee Generics Hearing Planned For June
The House Energy & Commerce Committee/Health Subcommittee intends to hold a hearing on generic drug issues in June.
PDUFA III Could Move Through Congress In 2001, Rep. Burr Suggests
FDA's post-approval surveillance system should be discussed as part of the reauthorization process for the Prescription Drug User Fee Act, Rep. Richard Burr (R-N.C.) said during a May 3 House Energy & Commerce Committee/Health Subcommittee hearing on implementation of the FDA Modernization Act.
House Commerce Health Subcommittee Generics Hearing Planned For June
The House Energy & Commerce Committee/Health Subcommittee intends to hold a hearing on generic drug issues in June.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: